The German Priority Program SPP 1276 “Multiple Scales in Fluid Mechanics and Meteorology” (MetStröm)

The German Priority Program SPP 1276 “Multiple Scales in Fluid Mechanics and Meteorology” (MetStröm)

Bibliographic Details
Main Authors:	Rupert Klein, Dieter Etling, Thomas von Larcher
Format:	Article
Language:	English
Published:	Borntraeger 2014-09-01
Series:	Meteorologische Zeitschrift
Subjects:	MetStroem
Online Access:	http://dx.doi.org/10.1127/metz/2014/0650

Similar Items

Results from the German Priority Program SPP 1276 “Multiple Scales in Fluid Mechanics and Meteorology” (MetStröm), Part II.
by: Rupert Klein, et al.
Published: (2015-01-01)

Auto-renouvellement des cellules souches melanocytaires : rôle des kinases RAF et MET
by: Barbotin, Céline
Published: (2016)

Roles of MET in Cancer Development and Treatment
Published: (2023)

Effectiveness of Thai-German Multidisciplinary Endoscopic Training (TG-MET) simulator for laparoscopic training
by: Thanatchaporn Baingam, et al.
Published: (2021-03-01)

Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
by: Li Liu, et al.
Published: (2021-06-01)

Tackling CASMI 2012: Solutions from MetFrag and MetFusion
by: Steffen Neumann, et al.
Published: (2013-08-01)

Dégradation du récepteur tyrosine kinase Met par clivages protéolytiques
by: Ancot, Frédéric
Published: (2010)

Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date
by: Bylicki O, et al.
Published: (2020-06-01)

MET and Small-Cell Lung Cancer
by: Francesco Gelsomino, et al.
Published: (2014-10-01)

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
by: Nichola Cruickshanks, et al.
Published: (2017-07-01)

Molecular Engineering Strategies Tailoring the Apoptotic Response to a MET Therapeutic Antibody
by: Chiara Modica, et al.
Published: (2020-03-01)

Estimativa do equivalente metabólico (MET) de um protocolo de exercícios físicos baseada na calorimetria indireta Estimation of metabolic equivalent (MET) of an exercise protocol based on indirect calorimetry
by: Christianne de Faria Coelho-Ravagnani, et al.
Published: (2013-04-01)

Cyclic Peptide-Based Biologics Regulating HGF-MET
by: Hiroki Sato, et al.
Published: (2020-10-01)

The role of HGF/c-MET signaling pathway in lymphoma
by: Bao Quoc Lam, et al.
Published: (2016-12-01)

c-MET and KRAS: Signalling and Clinical Implications in Colorectal Cancer
by: Organ, Shawna L.
Published: (2013)

c-MET and KRAS: Signalling and Clinical Implications in Colorectal Cancer
by: Organ, Shawna L.
Published: (2013)

Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case–control study
by: Kalapanida D, et al.
Published: (2019-05-01)

The COMT Val158Met Polymorphism and Reaction to a Transgression: Findings of Genetic Associations in Both Chinese and German Samples
by: Cornelia Sindermann, et al.
Published: (2018-08-01)

Decreased expression of Met during differentiation in rat lung
by: T. Kato, et al.
Published: (2016-02-01)

c-Met and miRs in Cancer
by: Simona Giglio, et al.
Published: (2015-01-01)

Long-term efficacy of crizotinib in a metastatic papillary renal carcinoma with MET amplification: a case report and literature review
by: Philippe Rochigneux, et al.
Published: (2018-11-01)

MET Inhibitors for the Treatment of Gastric Cancer: What’s Their Potential?
by: El Darsa H, et al.
Published: (2020-10-01)

Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma
by: Joycelyn J. X. Lee, et al.
Published: (2015-10-01)

Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation
by: Shinkichi Takamori, et al.
Published: (2021-03-01)

Tubeimoside-1 Inhibits Glioblastoma Growth, Migration, and Invasion via Inducing Ubiquitylation of MET
by: Jiangjun Cao, et al.
Published: (2019-07-01)

The Pathogenetic Role of the HGF/c-Met System in Papillary Carcinoma of the Thyroid
by: Luigi Ruco, et al.
Published: (2014-10-01)

HGF/MET and the Immune System: Relevance for Cancer Immunotherapy
by: Federica Papaccio, et al.
Published: (2018-11-01)

Structural and Functional Insight Into the Glycosylation Impact Upon the HGF/c-Met Signaling Pathway
by: Xinyue Hu, et al.
Published: (2020-06-01)

MET Inhibition in Non-Small Cell Lung Cancer
by: Shabnam Rehman, et al.
Published: (2019-03-01)

VHH-Photosensitizer Conjugates for Targeted Photodynamic Therapy of Met-Overexpressing Tumor Cells
by: Raimond Heukers, et al.
Published: (2019-04-01)

Correlation of MET and PD-L1 Expression in Malignant Melanoma
by: Kyu Young Song, et al.
Published: (2020-07-01)

HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation
by: Anna Spina, et al.
Published: (2015-01-01)

Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in <i>MET</i>-Addicted Cancer
by: Jooseok Kim, et al.
Published: (2020-06-01)

MET-overexpressing myxofibrosarcoma frequently exhibit polysomy of chromosome 7 but not MET amplification, especially in high-grade cases: clinical and pathological review of 30 myxofibrosarcoma cases
by: Shirong Ma, et al.
Published: (2018-08-01)

HGF/MET Signaling in Malignant Brain Tumors
by: Elizabeth Qian Xu Mulcahy, et al.
Published: (2020-10-01)

cMET in NSCLC: Can We Cut off the Head of the Hydra? From the Pathway to the Resistance
by: Nele Van Der Steen, et al.
Published: (2015-03-01)

Comprehensive comparison of MetAP2 tissue and cellular expression pattern in lean and obese rodents
by: Han J, et al.
Published: (2018-09-01)

Introdução ao METS – Preservação e Intercâmbio de Objetos Digitais
by: Nelson de Almeida Rodrigues
Published: (2008-10-01)

Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients
by: Patricia Mondelo-Macía, et al.
Published: (2020-02-01)

Lipocalin-2 Inhibits Osteosarcoma Cell Metastasis by Suppressing MET Expression via the MEK–ERK Pathway
by: Ko-Hsiu Lu, et al.
Published: (2021-06-01)